Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Color Diagnostics, |
RCV001183922 | SCV001349770 | uncertain significance | Cardiomyopathy | 2023-04-21 | criteria provided, single submitter | clinical testing | This missense variant replaces leucine with methionine at codon 248 of the TMEM43 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has not been reported in individuals affected with cardiovascular disorders in the literature. This variant has been identified in 8/281422 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. |
Labcorp Genetics |
RCV001244427 | SCV001417647 | uncertain significance | Arrhythmogenic right ventricular dysplasia 5 | 2024-01-21 | criteria provided, single submitter | clinical testing | This sequence change replaces leucine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 248 of the TMEM43 protein (p.Leu248Met). This variant is present in population databases (rs780389237, gnomAD 0.006%). This variant has not been reported in the literature in individuals affected with TMEM43-related conditions. ClinVar contains an entry for this variant (Variation ID: 923336). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Gene |
RCV001529347 | SCV001996910 | uncertain significance | not provided | 2023-12-28 | criteria provided, single submitter | clinical testing | Has not been previously published as pathogenic or benign to our knowledge; In silico analysis supports that this missense variant does not alter protein structure/function |
Ambry Genetics | RCV002379711 | SCV002668507 | benign | Cardiovascular phenotype | 2023-10-26 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Fulgent Genetics, |
RCV002505782 | SCV002814366 | uncertain significance | Arrhythmogenic right ventricular dysplasia 5; Emery-Dreifuss muscular dystrophy 7, autosomal dominant; Auditory neuropathy, autosomal dominant 3 | 2021-07-21 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001529347 | SCV003799420 | uncertain significance | not provided | 2022-04-26 | criteria provided, single submitter | clinical testing | The TMEM43 c.742C>A; p.Leu248Met variant (rs780389237), to our knowledge, is not reported in the medical literature but is reported in ClinVar (Variation ID: 923336). This variant is reported in the non-Finnish European population with an overall allele frequency of 0.006% (8/128,976 alleles) in the Genome Aggregation Database. The leucine at codon 248 is moderately conserved but computational analyses are uncertain whether this variant is neutral or deleterious (REVEL: 0.181). Due to limited information, the clinical significance of the p.Leu248Met variant is uncertain at this time. |
Molecular Genetics, |
RCV001244427 | SCV004812870 | uncertain significance | Arrhythmogenic right ventricular dysplasia 5 | 2023-09-04 | criteria provided, single submitter | clinical testing | This sequence change in TMEM43 is predicted to replace leucine with methionine at codon 248, p.(Leu248Met). The leucine residue is highly conserved (100 vertebrates, UCSC), and is located in the perinuclear space. There is a small physicochemical difference between leucine and methionine. The highest population minor allele frequency in the population database gnomAD v2.1 is 0.006% (8/128,976 alleles) in the European non-Finnish population. To our knowledge, this variant has not been previously reported in the relevant scientific literature or databases. Computational evidence predicts a benign effect for the missense substitution (REVEL = 0.181). Based on the classification scheme RMH Modified ACMG/AMP Guidelines v1.6.1, this variant is classified as a VARIANT OF UNCERTAIN SIGNIFICANCE. Following criteria are met: BP4 |
All of Us Research Program, |
RCV001244427 | SCV004841554 | uncertain significance | Arrhythmogenic right ventricular dysplasia 5 | 2023-08-15 | criteria provided, single submitter | clinical testing | This missense variant replaces leucine with methionine at codon 248 of the TMEM43 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has not been reported in individuals affected with cardiovascular disorders in the literature. This variant has been identified in 8/281422 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. |
Diagnostic Laboratory, |
RCV001529347 | SCV001742628 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001529347 | SCV001969919 | likely benign | not provided | no assertion criteria provided | clinical testing |